Potential Therapeutic Targets and Promising Agents for Combating NAFLD
Sign Up to like & getrecommendations! Published in 2022 at "Biomedicines"
DOI: 10.3390/biomedicines10040901
Abstract: Nonalcoholic fatty liver disease (NAFLD), including nonalcoholic steatohepatitis (NASH), is a growing cause of liver cirrhosis and liver cancer worldwide because of the global increases in obesity, dyslipidemia, hypertension, and type 2 diabetes mellitus. Contrary… read more here.
Keywords: agents combating; promising agents; targets promising; combating nafld ... See more keywords